A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial.

Peptides delivered on the surface of influenza virosomes have been shown to induce solid humoral immune responses in experimental animals. High titers of peptide-specific antibodies were also induced in a phase 1a clinical trial in volunteers immunized with virosomal formulations of two peptides der...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Shinji L Okitsu, Olivier Silvie, Nicole Westerfeld, Marija Curcic, Andreas R Kammer, Markus S Mueller, Robert W Sauerwein, John A Robinson, Blaise Genton, Dominique Mazier, Rinaldo Zurbriggen, Gerd Pluschke
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Public Library of Science (PLoS) 2007-12-01
Edice:	PLoS ONE
On-line přístup:	http://europepmc.org/articles/PMC2093993?pdf=render
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!